Moderna (MRNA) PT Raised to $180 as Jefferies Sees Positive Newsflow Likely to Continue and is "Significantly Above Consensus"
Tweet Send to a Friend
Jefferies analyst Michael Yee raised the price target on Moderna (NASDAQ: MRNA) to $180.00 (from $150.00) on the belief there ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
